Health Condition 1: E250- Congenital adrenogenital disordersassociated with enzyme deficiency
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Maulana Azad Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed cases of Congenital adrenal hyperplasia aged 5-18 years
Exclusion criteria
Exclusion criteria: Patients with inherent bone conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure markers of bone mineral metabolism Calcium, Phosphate, Alkaline Phosphatase, Vitamin D, Parathyroid Hormone (PTH) and Osteocalcin in patients with Congenital Adrenal Hyperplasia in children and adolescents aged 5-18 yearsTimepoint: To measure markers of bone mineral metabolism Calcium, Phosphate, Alkaline Phosphatase, Vitamin D, Parathyroid Hormone (PTH) and Osteocalcin in patients with Congenital Adrenal Hyperplasia in children and adolescents aged 5-18 years who are already on steroids since birth on follow up stat sample taken on Day 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| In children with Congenital Adrenal Hyperplasia 1. To evaluate the association of these markers with projected adult height 2. To study the association of these markers with duration, dose and type of steroids 3. To correlate the levels of these markers with Tanner Staging in age group of 9-18 yearsTimepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Seema Kapoor
Maulana Azad Medical College
Outcome results
None listed